Cyclobenzaprine oral tablet is a generic drug prescribed to treat muscle spasms from short term, painful, muscular conditions. It’s approved as an add-on treatment alongside rest and physical therapy.

Cyclobenzaprine is a generic prescription drug used to treat muscle spasms. The drug comes as a tablet that you swallow. It’s usually taken three times per day. Cyclobenzaprine is used in adults and ...

Cyclobenzaprine is a generic drug that’s prescribed for muscle spasms. As with other drugs, cyclobenzaprine can cause side effects, such as drowsiness and anxiety. Cyclobenzaprine oral tablets are not ...

Cyclobenzaprine is a generic prescription oral tablet used to treat muscle spasms. It does not come in any brand-name versions. Cyclobenzaprine can cause mild to serious side effects, including ...

A dose of Flexeril (cyclobenzaprine) causes sleepiness within 30 minutes, with effects lasting for up to six to eight hours. This muscle relaxer shouldn't be taken for long—it’s typically only ...

Review the side-effects of Cyclobenzaprine as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of ...

Cyclobenzaprine HCl 5mg, 7.5mg, 10mg; tabs. Cyclobenzaprine HCl relieves skeletal muscle spasm of local origin without interfering with muscle function. It is ineffective in muscle spasm due to ...

The FDA has approved cyclobenzaprine hydrochloride sublingual tablets (Tonmya, Tonix Pharmaceuticals), a first-in-class, nonopioid treatment for adults with fibromyalgia, a chronic pain syndrome that ...

Discover comprehensive details about Cyclobenzaprine, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it. The updated ...

Feb. 21, 2006 -- The US Food and Drug Administration (FDA) has approved first-time generic formulations of cyclobenzaprine HCl 5-mg tablets for adjunctive use in the short-term treatment of muscle ...

Unichem Pharmaceuticals has issued a voluntary recall of Cyclobenzaprine Hydrochloride Tablets USP 10 mg after the incorrect label was placed on the wrong product. FDA announced on Aug. 27, 2025 that ...